Like other cancer types, CRC displays a wide spectrum of TP53 mutations, which are observed in approximately 60% of all CRC tumors and are usually associated with the transition from large adenoma to invasive carcinoma20. This evidence concerns the gene TP53 and colorectal carcinoma.